ENVOY MEDICAL, INC. (COCH) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $329.79M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-122.00K; Retained Earnings (Accumulated Deficit)USD $-326.37M.
- 2026-03-31: Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $329.37M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-121.00K; Retained Earnings (Accumulated Deficit)USD $-319.10M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $301.36M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-120.00K; Retained Earnings (Accumulated Deficit)USD $-313.40M.
- 2025-09-30: Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $298.12M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-120.00K; Retained Earnings (Accumulated Deficit)USD $-305.66M.
ENVOY MEDICAL, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital, Common Stock USD | Retained Earnings, Appropriated USD | Common Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.00K | $329.79M | $-122.00K | $-326.37M | $3.30M | 3 month · $214.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $8.00K | $329.37M | $-121.00K | $-319.10M | $10.16M | 3 month · $239.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.00K | $301.36M | $-120.00K | $-313.40M | $-12.16M | 12 month · $657.00K | 12 month · $1.57M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $2.00K | $298.12M | $-120.00K | $-305.66M | $-7.66M | 3 month · $172.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $2.00K | $268.17M | $-119.00K | $-297.91M | $-29.86M | 3 month · $146.00K | 3 month · $882.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $2.00K | $266.86M | $-117.00K | $-290.97M | $-24.22M | 3 month · $160.00K | 3 month · $688.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.00K | $266.01M | $-123.00K | $-284.73M | $-18.84M | 12 month · $562.00K | 12 month · $1.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $259.12M | $-121.00K | $-277.54M | $-18.54M | 3 month · $144.00K | 3 month · $699.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $257.92M | $-120.00K | $-270.20M | $-12.40M | 3 month · $142.00K | 3 month · $197.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $257.58M | $-119.00K | $-264.89M | $-7.43M | 3 month · $123.00K | 3 month · $179.00K | 3 month · $1.68M | $179.38K | $264.90M | (m) | (m) | (m) |
| 2024-02-29 | (m) | $2.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $255.60M | $-118.00K | $-257.26M | $-1.78M | 12 month · $1.57M | (m) | 12 month · $18.70M | (m) | $257.20M | $750.00K | (m) | 12 month · $4.50M |
| 2023-09-30 | (m) | $255.91M | $-116.00K | $-251.01M | $4.79M | (m) | (m) | 3 month · $1.04M | (m) | $251.00M | (m) | (m) | 9 month · $5.40M |
| 2023-06-30 | (m) | (m) | (m) | $-20.79M | $-45.12M | (m) | (m) | 3 month · $15.71M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | $-19.22M | $-47.49M | (m) | (m) | 3 month · $1.95M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $189.90M | $-115.00K | $-225.99M | $-36.20M | (m) | (m) | 12 month · $4.72M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | $-17.35M | $-25.55M | (m) | (m) | 3 month · $1.98M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | $-21.45M | $-26.18M | (m) | (m) | 3 month · $645.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-24.25M | $-25.59M | (m) | (m) | 3 month · $1.27M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $-36.71M | $-44.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | $-32.77M | $-32.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $6.10M | (m) | $-38.33M | $-38.33M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $280.50K | (m) |
| 2021-03-31 | (m) | $6.47M | (m) | $-38.26M | $-38.26M | (m) | 3 month · $782.81K | (m) | (m) | (m) | (m) | 3 month · $631.84K | (m) |
| 2021-03-04 | (m) | (m) | (m) | $-37.46M | $-37.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $23.79K | (m) | $-701.00 | $24.30K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |